Single Dose Study of Tulisokibart (MK-7240) in Healthy Chinese Participants (MK-7240-002)

Clinical trial NCT06829225 · COMPLETED

Trial details

NCT number: NCT06829225
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Colitis, Ulcerative

Start date: 2024-06-13
Primary completion: 2024-11-11
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.